Epidemiological and Clinical Characteristics of Deceased COVID-19 Patients

Mohammed Badedi1, Hussain Darraj1, Awaji Qasem Alnami1

  • 1General Directorate of Health Affairs, Jazan, Jazan Region, Saudi Arabia.

Insights

Fatalities from coronavirus disease 2019 (COVID-19) were high among older Saudi patients with comorbidities like diabetes and hypertension. Advanced age, smoking, and respiratory failure were key predictors of mortality in hospitalized patients.

Area of Science:

  • Epidemiology
  • Clinical Medicine
  • Public Health

Background:

  • Coronavirus disease 2019 (COVID-19) fatalities are rising globally.
  • Limited data exists on COVID-19 mortality in the Arab region, particularly concerning hospitalized patients.
  • This study addresses the gap in understanding COVID-19 epidemiological and clinical characteristics in deceased patients.

Purpose of the Study:

  • To investigate the epidemiological and clinical features of patients who died from COVID-19 in Saudi Arabia.
  • To identify risk factors associated with mortality in hospitalized COVID-19 patients.

Main Methods:

  • Retrospective cohort study of 304 Saudi patients who died from COVID-19.
  • Data collected from July 1, 2020, to December 31, 2020, in the Jazan Region.
  • Analysis included patient demographics, comorbidities, clinical symptoms, laboratory findings, and radiological data.

Main Results:

  • Males (59%) and patients aged ≥65 years (55%) constituted the majority of deaths.
  • High prevalence of comorbidities: diabetes (70%), hypertension (69%), obesity (30%).
  • Common symptoms: dyspnea (91%), cough (80%), fever (70%). Most patients required ICU admission (85%) and mechanical ventilation (90%).
  • Key predictors of mortality included higher age, smoking, elevated creatinine and aspartate transaminase levels, and respiratory failure.

Conclusions:

  • Deceased COVID-19 patients in Jazan region, Saudi Arabia, exhibited a high burden of comorbidities.
  • Advanced age, smoking, and respiratory failure are significant predictors of mortality in hospitalized COVID-19 patients.
  • Findings highlight the need for targeted interventions for high-risk populations.
Abstract

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
807
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
59
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.2K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
534
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
91
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
58